Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 334,604 | 27,435 | 29,641 | 31,433 | 119,753 | -- |
| General And Administrative Expense | 333,237 | 27,435 | 29,641 | 31,433 | 118,151 | -- |
| Other Operating Expenses | 9,964 | 17,296 | 10,230 | 3,163 | 8,142 | -- |
| Operating Expense | 344,568 | 44,731 | 39,871 | 34,596 | 127,895 | -- |
| Operating Income | -344,568 | -44,731 | -39,871 | -34,596 | -127,895 | -- |
| EBIT | -344,568 | -44,731 | -39,871 | -34,596 | -127,895 | -- |
| Interest Income | 711.00 | 514.00 | 764.00 | 1,811 | -275.00 | -- |
| Interest Income Non Operating | 711.00 | 514.00 | 764.00 | 1,811 | -275.00 | -- |
| Net Interest Income | 711.00 | 514.00 | 764.00 | 1,811 | -275.00 | -- |
| Other Income Expense | -- | -- | -- | -- | 0.00 | -47,670 |
| Special Income Charges | 0.00 | 0.00 | -- | -- | 0.00 | -47,670 |
| Pretax Income | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Net Income From Continuing Operation Net Minority Interest | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Net Income Including Noncontrolling Interests | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Net Income Common Stockholders | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Net Income | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| EBITDA | -344,568 | -44,731 | -39,871 | -34,596 | -127,895 | -- |
| Normalized EBITDA | -344,568 | -44,731 | -39,871 | -34,596 | -127,895 | -- |
| Basic EPS | -- | -0.00 | -0.00 | -0.00 | -- | -0.00 |
| Diluted EPS | -- | -0.00 | -0.00 | -0.00 | -- | -0.00 |
| Basic Average Shares | -- | 106.6M | 106.6M | 106.6M | -- | 105.1M |
| Diluted Average Shares | -- | 106.6M | 106.6M | 106.6M | -- | 105.1M |
| Total Unusual Items | 0.00 | 0.00 | -- | -- | 0.00 | -47,670 |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | -- | -- | 0.00 | -47,670 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Diluted NI Availto Com Stockholders | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Impairment Of Capital Assets | 0.00 | 0.00 | -- | -- | 0.00 | 47,670 |
| Insurance And Claims | 57.00 | 0.00 | 0.00 | 1,250 | 1,250 | -- |
| Net Income Continuous Operations | -343,857 | -44,217 | -39,107 | -32,785 | -128,170 | -- |
| Net Non Operating Interest Income Expense | 711.00 | 514.00 | 764.00 | 1,811 | -275.00 | -- |
| Other Gand A | 60,180 | 27,435 | 29,641 | 30,183 | 68,269 | -- |
| Salaries And Wages | 273,000 | 0.00 | 0.00 | 0.00 | 48,632 | -- |
| Selling And Marketing Expense | -- | -- | -- | 0.00 | -- | -- |
| Total Expenses | 344,568 | 44,731 | 39,871 | 34,596 | 127,895 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 154,482 | 151,447 | 76,139 | 115,164 | 130,576 | -- |
| Cash Cash Equivalents And Short Term Investments | 154,482 | 151,447 | 76,139 | 115,164 | 130,576 | -- |
| Cash Equivalents | -- | 145,000 | 68,000 | 90,000 | -- | -- |
| Cash Financial | 154,482 | 6,447 | 8,139 | 25,164 | 130,576 | -- |
| Accounts Receivable | 9,394 | 6,437 | 5,960 | 3,992 | 12,093 | -- |
| Receivables | 9,394 | 6,437 | 5,960 | 3,992 | 12,093 | -- |
| Prepaid Assets | 2,942 | 0.00 | 0.00 | 0.00 | 1,250 | -- |
| Current Assets | 166,818 | 157,884 | 82,099 | 119,156 | 143,919 | -- |
| Net PPE | 932,752 | 932,752 | 1.0M | 1.0M | 1.0M | -- |
| Total Non Current Assets | 932,752 | 932,752 | 1.0M | 1.0M | 1.0M | -- |
| Total Assets | 1.1M | 1.1M | 1.1M | 1.2M | 1.2M | -- |
| Payables And Accrued Expenses | 35,806 | 68,653 | 48,651 | 46,602 | 38,580 | -- |
| Current Liabilities | 35,806 | 68,653 | 48,651 | 46,602 | 38,580 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 35,806 | 68,653 | 48,651 | 46,602 | 38,580 | -- |
| Common Stock | 15.7M | 15.6M | 15.6M | 15.6M | 15.6M | -- |
| Capital Stock | 15.7M | 15.6M | 15.6M | 15.6M | 15.6M | -- |
| Retained Earnings | -16.9M | -16.6M | -16.5M | -16.5M | -16.5M | -- |
| Gains Losses Not Affecting Retained Earnings | 2.3M | 2.0M | 2.0M | 2.0M | 2.0M | -- |
| Other Equity Adjustments | 2.3M | 2.0M | 2.0M | 2.0M | 2.0M | -- |
| Common Stock Equity | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M | -- |
| Stockholders Equity | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M | -- |
| Total Equity Gross Minority Interest | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M | -- |
| Total Capitalization | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M | -- |
| Net Tangible Assets | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M | -- |
| Tangible Book Value | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M | -- |
| Working Capital | 131,012 | 89,231 | 33,448 | 72,554 | 105,339 | -- |
| Invested Capital | 1.1M | 1.0M | 1.1M | 1.1M | 1.1M | -- |
| Share Issued | 108.7M | 106.6M | 106.6M | 106.6M | 106.6M | -- |
| Ordinary Shares Number | 108.7M | 106.6M | 106.6M | 106.6M | 106.6M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -34,465 | -24,692 | -39,025 | -15,412 | 7,430 | -- |
| Cash Flow From Continuing Operating Activities | -34,465 | -24,692 | -39,025 | -15,412 | 7,430 | -- |
| Stock Based Compensation | 273,000 | 0.00 | 0.00 | 0.00 | 48,632 | -- |
| Change In Working Capital | 36,392 | 19,525 | 81.00 | 17,373 | 86,968 | -- |
| Changes In Account Receivables | -2,957 | -477.00 | -1,968 | 8,101 | -3,369 | -- |
| Change In Receivables | -2,957 | -477.00 | -1,968 | 8,101 | -3,369 | -- |
| Change In Payables And Accrued Expense | 42,291 | 20,002 | 2,049 | 8,022 | 89,087 | -- |
| Purchase Of PPE | -- | -- | -- | 0.00 | -- | -- |
| Net PPE Purchase And Sale | -- | -- | -- | 0.00 | -- | -- |
| Investing Cash Flow | 0.00 | 100,000 | 0.00 | 0.00 | -39,344 | -- |
| Cash Flow From Continuing Investing Activities | 0.00 | 100,000 | 0.00 | 0.00 | -39,344 | -- |
| Financing Cash Flow | 37,500 | 0.00 | -- | -- | -7,714 | 0.00 |
| Cash Flow From Continuing Financing Activities | 37,500 | 0.00 | -- | -- | -7,714 | 0.00 |
| Changes In Cash | 3,035 | 75,308 | -39,025 | -15,412 | -39,628 | -- |
| Beginning Cash Position | 151,447 | 76,139 | 115,164 | 130,576 | 170,204 | -- |
| End Cash Position | 154,482 | 151,447 | 76,139 | 115,164 | 130,576 | -- |
| Free Cash Flow | -34,465 | -24,692 | -39,025 | -15,412 | 7,430 | -- |
| Asset Impairment Charge | 0.00 | -- | -- | -- | 0.00 | -- |
| Change In Prepaid Assets | -2,942 | 0.00 | 0.00 | 1,250 | 1,250 | -- |
| Net Income From Continuing Operations | -343,857 | -44,217 | -39,106 | -32,785 | -128,170 | -- |
| Net Other Financing Charges | -- | -- | -- | -- | -7,714 | 0.00 |
| Net Other Investing Changes | -- | -- | -- | -- | -- | 107,396 |